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A b s t r a c t  
Several technical factors related to penicillin G intramuscular injection can affect its bioavailability 
and hence reduce the efficacy of rheumatic fever prevention program. When small amount of diluent 
is used, the powder is not completely dissolved and the thick suspension frequently causes 
obstruction of injection needle. The study aimed to characterize the solid-state properties of solid 
dispersion systems of benzathine penicillin G (BPG) prepared with hydrophilic carriers by applying 
solvent evaporation method. The results of spectroscopic studies; Fourier transform-infra red (FTIR), 
Nuclear Magnetic Spectroscopy (1HNMR) and Differential Scanning Calorimetry (DSC) revealed no 
chemical interaction between the drug and carriers. No significant changes in drug crystalline state 
were observed by X-ray diffraction and Scanning Electron Microscope (SEM) studies, even with 
using amorphous carriers; polyvinyl pyrrolidone (PVP-K30) and hydroxypropyl methylcellulose 
(HPMC). All the prepared solid dispersions demonstrated 76-93% yield and % drug content 
dependent on the polymer type and concentration. The hydrophilic polymers demonstrated potential 
effect on improving the flowability, wettability and dissolution characters of the drug. The results 
revealed that it is possible to enhance the dissolution rate of BPG (hydrophobic drug) by increasing 
the surface area of the drug adsorbed on the surface of hydrophilic polymer by solid dispersion 
method. Finally, solid dispersion BPG: PEG 4000 at ratio 50:50 gave uniform flowability of the 
powder (around 30), wettability (12 min) and faster dissolution rates among all the formulations. 
Thus, it was selected as the best formulation in this study. 
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Introduction  
Benzathine penicillin G (BPG) is a semi-synthetic compound 
derived from natural penicillin through the inclusion of a benzyl ring 
in the ß-lactamic group. The molecular mass is 981.19 Daltons that 
makes the drug very slightly soluble in water and sparingly soluble 
in alcohol [1]. The antibacterial activity of BPG is mainly against 
Gram-positive bacteria (including actinomycetes) and some Gram-
negative Cocci, as well as some spirochetes. BPG is widely used 
in the treatment of numerous infectious diseases, especially those 
related to obstetric and gynecologic conditions. In general, 
penicillin is effective in the treatment of localized skin and soft-
tissue infections of the nose, throat, lower respiratory tract and 
genitourinary tract The solubility of the penicillin in the blood and 
biological fluids is also rather limited; hence it is applied 
intramuscularly as a depot therapy in treatments that require low 
and constant blood levels for a long period of time [2]. 
Despite the high burden of rheumatic heart disease (RHD) globally, 
there has never been a sustained and comprehensive international 
strategy to control. The global efforts to combat the disease are 
based on strengthening the secondary prophylaxis strategies. 
Monthly injections of 1,200,000 UI of BPG (1mg) is considered as 
the first-line treatment for streptococcal infections [2, 3]. The BPG 
dosage form available in the pharmaceutical market is the 
sustained-release intramuscular injection suspension. But its 
variable physical properties, such as solubility, viscosity and crystal 
size, deviations on its bioavailability and release profile, pain and 
lack of patient compliance have meant in treatment failure [4,5]. 
Many trials were developed to prepare BPG in suitable injectable 
forms. Use of lidocaine hydrochloride as a diluent for benzathine 
penicillin significantly reduces the pain of injection without affecting 
penicillin concentration in body fluids [6]. Santos-Magalhães et.al 
(2000) carried out formulation of benzathine penicillin G in nano 
emulsion and nanocapsules dosage forms [7]. Holanda e Silva 
et.al (2006) demonstrated the ability to incorporate BPG into 
micellar system, which increases its apparent solubility in water. 
The incorporated drug is also expected to exhibit improved 
stability, since the antibiotic enclosed in the hydrophobic core of 
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micelles is rather shielded from the aqueous external environment 
[8]. 
Solid dispersion is an important pharmaceutical technology that 
has been commonly used to improve dissolution and bioavailability 
of poorly water-soluble drugs. This technique is based on 
dispersion of the drug into an inert, hydrophilic polymer matrix and 
the increase in the rate of drug dissolution is due to the following 
factors: reduction of the drug particle size to molecular level, 
solubilizing effect on the drug by the water-soluble carrier and 
enhancement of the wettability and dispersibility of the drug by the 
carrier material [9-12]. Other factors such as eutectic formation, 
increased surface area of the drug due to precipitation in the 
carrier, formation of true solid solution, precipitation as a 
metastable crystalline form or a decrease in substance crystallinity 
may also contribute to increased dissolution [13]. Many carriers 
such as polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), 
hydroxypropyl methylcellulose (HPMC), and mannitol have been 
reported to improve the solubility and bioavailability of poorly water-
soluble drugs [14, 15]. Till now, no formulation of BPG has been 
developed to keep the drug activity, stability and improve patient 
compliance. The purpose of this study is to utilize the potentials of 
the solid dispersion technique for the development of injectable 
suspension of BPG as a promising means to improve its 
bioavailability and treatment of rheumatic fever. The 
physicochemical properties of the prepared solid dispersions with 
different water-soluble carriers, mannitol, PEG4000, HPMC, and 
PVP were comprehensively evaluated to select the appropriate 
carrier. The drug and carriers interaction was evaluated using 
Fourier transform infrared spectroscopy (FTIR), Nuclear magnetic 
resonance (NMR), and differential scanning calorimetry (DSC). The 
prepared formulations were further investigated for crystallinity, 
drug content, flowability, wettability and in vitro dissolution rate 
studies. 
Materials and methods 
Materials 
Benzathine penicillin G (BPG) was provided by Chemical Industries 
Development (CID), (Cairo, Egypt). Polyvinyl pyrrolidone (PVP-
K30) with a molecular weight of 50,000-55,000 and hydroxypropyl 
methylcellulose (HPMC) were obtained from National 
Pharmaceutical Industries Co. (NP Pharm, Russayl, Sultanate of 
Oman). Polyethylene glycol (PEG 4000) with a molecular weight of 
3898 g/mol was obtained from Hoechst Chemikalien (Germany). D 
(-) Mannitol was purchased from BDH chemical (England). All other 
materials and reagents were of analytical grade. 
Methods  
Preparation of Benzathine Penicillin G Solid Dispersions 
Benzathine penicillin G solid dispersions were prepared by solvent 
evaporation method (18), using mannitol, PEG4000, PVP and 
HPMC at two ratios 50:50 and 70:30. Accurately weighed drug was 
dissolved in 25 ml of ethanol and dichloromethane mixture at ratio 
2:3. The organic solution of the drug was poured into magnetically 
stirred (IKA Works, (Asia) Sdn. Bhd., Malaysia) aqueous solution of 
the polymer with least amount of water (3 ml) in porcelain dish. The 
solvents were allowed to evaporate by constant stirring at room 
temperature. The dispersions were kept at 40ĈC (JSR Oven, Made 
in Korea) for 24 hrs for complete dryness. The resultant solid 
dispersion was scraped out with a spatula, pulverized in a mortar 
and pestle and passed through a 150 μm sieve before packing in 
an airtight container. The composition of formulations were shown 
in table -1. 
Percentage Practical Yield 
Percentage practical yield was calculated in order to determine the 
efficiency of the method of preparation. Solid dispersions were 
collected and weighed to determine practical yield (PY) from the 
following equation. 
  
PY (%) =
Practical Mass (solid dispersion)
Theoretical mass ( Drug +Carrier)
X 100
 
Table I.  Percentage yield and drug content of BPG solid dispersions. 
  
Formualtions Drug : polymer ratio  50: 50% w/w Drug : polymer ratio  70: 30% w/w 
 Yield (%) Drug content (%) Yield (%) Drug content (%) 
BPG: PVP 76.8 29.1μ2.5 89.3 45.4μ1.8 
BPG: HPMC 80.0 38.5μ2.0 91.3 41.3μ1.5 
BPG: PEG 4000 76.7 40.5μ5.5 80.0 50.1μ1.1 
BPG: Mannitol 88.7 47.5μ5.0 93.3 39.4μ2.2 
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Drug Content Analysis 
Accurately weighed solid dispersions equivalent to 5 mg of BPG 
were dissolved in the 10 ml of methanol and filtered by using (0.22 
øm Nylon Millipore, USA). The drug content was directly analyzed 
at 257 nm by UV spectrophotometer (Perkin Elmer, Lambda Ez 
201, USA). The percentage drug content was calculated using the 
following equation:  
% Drug content = (weight of drug / weight of drug 
loaded solid dispersion) ï 100      
FT-IR Spectroscopy (FTIR) 
FTIR spectra were recorded on a Perkin-Elmer IR spectrometer 
(spectrum BX 100, Perkin-Elmer, USA). Samples were prepared in 
KBr discs (about 10 mg sample for 100 mg of dry KBr).  The IR 
spectra were obtained in the spectral region 450-4000 cm-1  
X-ray Diffraction (XRD) 
The powder X-ray diffraction (PXRD) patterns of pure ingredients 
and all solid dispersions were recorded using a wide angle x-rays 
diffraction (WAXD) experiments. The X-ray diffractometrer (Model 
(XÊ pert Pro, P-Analytical, Netherland) with Cu Kđ radiation at a 
generator voltage of 45KV and a generator current of 45mA was 
used. Samples were scanned from 2θ = 1.5Ĥ at a scanning rate of 
2Ĥ/min. 
1H NMR Spectroscopy  
1H NMR spectrum of pure compound and all solid dispersion 
samples were recorded in a BRUCKER Avance-400 MHz 
spectrometer (Biospin AG, Switzerland). Deuterated dimethyl 
sulfoxide (DMSO) was used as solvent.  
Differential Scanning Calorimetry (DSC) 
Samples for DSC (3-4 mg) were weighed in the aluminum pans 
(TA Instruments, Brussels, Belgium) and hermetically sealed. Runs 
were performed over temperature range 20-250 ĈC, at a constant 
rate of 5 ĈC/min under nitrogen purge (30 ml/min). Octadecane and 
indium standards were used to calibrate the DSC-7 calorimeter 
(Perkin-Elmer, Norwalk, CT).  
Scanning Electron Microscope (SEM) 
Morphological analysis of the drug, polymer and drug-polymer solid 
dispersions was performed using SEM (JEOL JSM-6510LA, Tokyo, 
Japan). The films were mounted with a double adhesive carbon 
tape in order to have good conductivity of the electron beam. The 
operating conditions were: accelerating voltage 1-10 kV, probe 
current 45 øA and a different magnification. 
Angle of repose 
It is the maximum possible angle between the surface of a powder 
heap and the horizontal plane. It was determined by applying the 
simple funnel method at fixed height (h). After the cone was 
formed, the radius (r) of the base was measured. The angle of 
repose (θ) was calculated using the following equation. 
θ = tan-1h/r, where r is the radius of the samples, h is the height of 
the samples. 
Wettability 
Sinking method described by Carino and Mollet (17) was used to 
measure of the effect of hydrophilic carries on improving the drug 
wetting by the aqueous medium. About 0.3 gm of the powder was 
distributed as thin layer on the surface of 100 ml distilled water. 
The time needed for the last traces of powder to sink (sinking time) 
was determined. 
In vitro drug release studies  
The dissolution study was carried out using USP XXVII Apparatus 
I (Hanson Research Dissolution tester, Chatsworth, USA.). 
The dissolution medium was 900 ml of phosphate buffer solution 
(PBS) with a pH of 7.4 kept at 37μ0.5 ĈC. The drug, solid 
dispersions were filled in empty hard gelatin capsules and then 
kept in the basket of dissolution apparatus rotating at 50 
rpm. At specified time intervals, samples of 1.0 
ml were withdrawn and replaced with fresh medium to provide the 
necessary sink condition. The samples were diluted with methanol 
up to 10.0 ml, filtered (0.22 øm Nylon membrane filter, Millipore, 
Millex®) and analyzed spectrophotometrically at 257 nm (Perkin 
Elmer, Lambda Ez 201, USA). 
Each preparation was tested in triplicate and the mean values were
 calculated. The cumulative percentage drug release was 
calculated to establish the drug release profiles of the BPG loaded 
solid dispersions. 
Results  
Percentage yield and drug content  
The percentage yield of the prepared solid dispersions were in the 
range of 76.7-93.3% Table 1. The results also showed that 
percentage drug content values were 29.1, 38.5, 40.5 and 47.5 
respectively.   
Angle of repose and powder wettability 
Angle of repose of solid dispersions prepared with PVP, HPMC 
and PEG 4000 at different ratios was ranged from 31.67 to 37.46 
and mannitol was 42.12 to 45. 63 in comparison to pure drug 44 
(Table -2).  The average wettability of pure BPG was found to be 
59 seconds. A minimum wetting time 12.5-22.2 and 8.3-18.5 
seconds was recorded for PEG 4000 and mannitol solid 
dispersions, respectively. Decreasing the polymers concentration 
(drug: polymer ratio 70:30) increased the wetting time by 10 
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seconds for both polymers. The HPMC had a little effect on the 
powder wetting.  At ratio 50:50  HPMC showed sinking time (45 
seconds) close to pure drug that also increased to reach 68 with 
decreasing the polymer ratio (70:30 BPG:HPMC) (Table -2). The 
maximum wetting time was observed for PVP dispersions. The 
wetting time of PBG: PVP dispersion (50:50) was 234 seconds and 
decreased to172 with decreasing the PVP concentration in the 
solid dispersion (PBG: PVP (70:30). 
 
 
Table 2. Flow and wetting properties of BPG and the formulated solid dispersions 
 
Solid dispersion formulations Angle of repose Powder wettabililty (sec)
 50:50% w/w 70:30% w/w 50:50% w/w 70:30% w/w
BPG: PVP 31.67μ0.47 37.46μ1.37 234μ8.48 172μ12.72
BPG: HPMC 36.50μ0.65 35.36μ1.00 45μ2.82 68μ5.65 
BPG: PEG 4000 34.06μ0.84 33.67μ1.28 12.5 μ3.35 22.2 μ4.24
BPG: Mannitol 45.63μ1.09 42.12μ2.68 8.3 μ0.35 18.5 μ0.71
BPG (pure drug)                         44.20μ0.91                     59 μ1.41
< 
FT -Infrared spectroscopy 
To evaluate the chemical compatibility between the drug and 
hydrophilic polymers, IR analysis was performed.  The FT-IR 
spectraÊs of BPG, polymers and their solid dispersion formulas 
were shown in Figure 1A-D. The spectrum of pure BPG exhibited a 
characteristic band at 3590cm-1 of NH stretching of amide group 
and three characteristic bands at 1762, 1658 and 1566cm-1, 
representing C=O stretching of the lactam, amide and carboxylate 
groups, respectively. Figure 1A, showed the characteristic 
absorption peaks of PVP K30 appeared at 3454 and 1654cmî 1, 
corresponding to stretching vibrations of ăOH and the carbonyl 
groups on the pyrrolidone ring. In the solid dispersion spectra, the 
characteristic peaks of both BPG and PVP were evidently 
observed. The spectrum of HPMC (Figure 1B) showed broad band 
at 3300-3500 cm-1 for -OH stretch and 1100 cm-1 for C-O bending. 
The FT-IR spectra of both the solid dispersions still showed the 
same bands for BPG and HPMC. Figure 1C, PEG 4000 spectrum 
showed its imperative peaks at 3425 cmă1, 2890 cm-1 and 1109 
cmă1 for -OH, - CH and C-O-C stretch, respectively. The solid 
dispersion showed the same bands in agreement with the chemical 
structures of BPG and PEG4000. Mannitol  spectrum (Figure 1D) 
showed bands of at 3400-3200 cm-1, 1421 cm-1, 1083 cm-1 and 
1019 cm-1  for O-H and CH2 stretching and C-O bending,  
respectively. Their solid dispersions also revealed no discrepancies 
in the position of the characteristic bands of both BPG and 
mannitol. 
 
 
 
Figure 1. FTIR of pure BPG, two solid dispersions and polymer. (A) PVP K30, (B) HPMC, (C) PEG 4000, (D) mannitol. 
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X-Ray Diffraction Analysis 
The x-ray diffracometrty (XRD) spectra of pure compound, polymer 
and their binary systems were presented in Figure 2A-D.  Sharp 
and intense crystalline peaks of the drug at 2θ of 16, 19, 19.5, 21, 
22, 23.5, 26, 29 Ĉ were observed in diffraction spectra.  Thus, a 
typical crystalline pattern of drug in all solid dispersions, 
irrespective to the polymer nature was recognized. The results 
showed that even with using PVP K30 and HPMC in amorphous 
state the less characteristics peaks corresponding to the drug 
(Figure 3A and B) was observed, indicating the presence of drug in 
an semicrystalline or dissolution state. The X-ray diffraction 
patterns (Figures 3C and D) also showed less intensity peaks of 
drug in the solid dispersion formulations revealed may be drug 
present in the form of semicrystalline or dissolution state or 
polymeric amorphous state, respectively. 
 
 
 
Figure 2. XRD of pure BPG, two solid dispersions and polymer.  (A) PVP K30, (B) HPMC, (C) PEG 4000, (D) mannitol. 
Differential scanning calorimetry (DSC)  
The thermal behaviour of the drug powder, carriers and solid 
dispersions were presented in Figure 3A-D. The BPG showed an 
endothermic peak at 124.22 ĈC - 127 ◦C.  Both PVP K30 and 
HPMC showed no thermograms peaks due to their amorphous 
state. A sharp endothermic peak was seen at 60.2 ĈC and 165-169 
◦C corresponding to the melting point of PEG 4000 and mannitol,  
 
 
 
respectively. The DSC of drug-polymers solid dispersions showed 
suppression and broadening in the DSC peaks. 
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Figure 3. DSC thermograms of BPG, two solid dispersions and polymer  (A) PVP K30, (B) HPMC, (C) PEG 4000, (D) mannitol. 
Scanning electron microscope (SEM) 
Figure 4A-D illustrates the SEM photomicrographs of pure 
materials and solid dispersions. The BPG exists as aggregates of 
crystalline particles of irregular size. Figure 4A, shows PVP K30 as 
amorphous spherical particles. The BPG: PVP solid dispersions 
appear in the form of tiny aggregates of irregular size pieces. In 
Figure 4B, HPMC exhibits cylindrical shaped particles similar to 
fibers in amorphous state. The solid dispersions showed 
aggregates of irregular particles with porous nature. Figure 4 C and 
D showed the crystalline state of both PEG 4000 and mannitol that 
appeared as smooth-surfaced flaks and needle, respectively. The 
drug-PEG 4000 solid dispersion showed the smallest crystalline 
particles at drug: polymer ratio 50:50 that showed obvious increase 
in size with decreasing polymer concentration (70:30). The drug-
mannitol solid dispersion showed aggregated crystals with smooth 
surface and irregular shape. 
In vitro dissolution studies 
 
 
The in-vitro release profiles of pure drug and solid dispersions at 
different ratios were shown in Figure 5 A and B.  The dissolution 
rates of BPG  solid dispersions using mannitol, PEG 4000, HPMC 
and PVP were much higher than the corresponding pure drug that 
allowed 16% maximum drug release after 60 min. Decreasing 
polymers concentration showed an obvious decrease in the 
percentage drug released (Figure 5B). At drug: mannitol ratio 
50:50, 57% drug was released during 60 min and decreased to 
49% with decreasing the polymer concentration to 30%. HPMC 
showed 61 and 51% drug release for drug: polymer ratio 50:50 and 
70:30, respectively at the end of 60 min. The drug: PEG 4000 at 
ratio 50:50 showed the greatest release profile (73%) than all other 
formulations. The effect of decreasing PEG concentration on the 
drug dissolution was very clear at ratio 70:30, that allowed only 
45% drug to be released.  
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Figure 5. SEM of BPG, two solid dispersions and polymer. (A) PVP K30, (B) HPMC, (C) PEG 4000, (D) mannitol. 
 
 
 Figure  5. In vitro release profiles of solid dispersions (A) 50:50, (B) 70:30.  (-Ë-) pure drug, (-□-) D: mannitol, (-ĥ-) D:PEG 4000, (-X-)  
          D: HPMC, (●) D:PVP. 
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Discussion  
Formulations and evaluation studies 
The percentage drug content showed high dependence on the 
polymer type and concentration. The effect of polymer type was 
clearly observed at drug: polymer ratio 50:50. Although satisfactory 
% yield was obtained with decreasing the polymer concentration 
(drug: polymer ratio 70:30) (Table -1). Such effect was clearly 
observed with mannitol, PEG 4000 and HPMC. This was probably 
due to effect of polymer concentration on increasing the viscosity of 
dispersion medium and hence decreasing the escaping of drug 
molecules from the polymer solution 
FTIR spectroscopy analysis. 
 
FTIR spectroscopy analysis was done to analyze physicochemical 
interactions between BPG and different hydrophilic carriers in form 
of solid dispersions. In the solid dispersion spectra, the 
characteristic bands of both BPG and PVP were evidently 
observed, and the spectra can be regarded as a simple 
superimposition of that of drug and the polymer. The same could 
be noticed for BPG and HPMC solid dispersions.  In the case of 
BPG and PEG4000 solid dispersions, any sign of interaction would 
be reflected by a transformation in the position of C=O vibration 
and disappearance of O-H stretching, which has not been 
observed in this instance indicating a significant absence of 
interaction between BPG and PEG 4000. Also the FTIR 
characterized solid dispersions of BPG and mannitol revealed no 
discrepancies in the position of the characteristic bands of both 
BPG and mannitol. The spectra of IR analysis revealed no 
difference in the position of absorption bands, especially with 
respect to OH, C=O, NH, hence providing the absence of hydrogen 
bonding interaction in solid state between polymers and BPG. 
X-Ray diffraction analysis 
In order to investigate both the polymorphic transformation, which 
would occurs during preparation of the solid dispersion, and the 
possible influence of carriers on phase transformation, X-ray 
diffraction was performed.  The only distinguished difference was 
the relative reduction in diffraction intensity of BPG in these 
preparations, suggesting a reduction on crystals size to the 
microcrystal form [16]. These results was also supported with 
published data [17] that in developing of a solid dispersion systems 
containing poorly water soluble drugs, the method of preparation 
plays an important role in the solubility and crystallinity of the 
drugs. In preparing of solid dispersion by surface-attached method, 
the organic solution of drug was poured into the mechanically 
stirred aqueous solution of the polymer that allowed drug 
precipitated may be as fine semicrystalline state. The method of 
preparation showed change in the drug crystalinity may be in the 
form of semicrystalline state or polymeric amorphous state as 
evidenced by low intensity characteristics peaks of drug in 
formulations. Additionally, the hydrophobic nature of the drug was 
expected to shift to hydrophilic one, as a result for attachment of 
the drug into the surface of hydrophilic carrierÊs molecules.  
DSC 
DSC technique draws attention to the interaction between the drug 
and excipients in its formulation. When guest molecules are 
included in host molecules, their melting, boiling and sublimation 
points shift to different temperature or disappear (16). The 
thermograms of the solid dispersions of BPG: PVP K30 and 
BPG:HPMC showed that the drug peak was suppressed and 
shifted, suggesting that the drug was able to dissolve in the carrier 
to form a solid-solid solution, as evidenced by XRD data. For BPG: 
PEG 4000 solid dispersions, the peak of PEG 4000 at 60.2◦C in 
solid dispersions is slightly shifted to lower temperature and no 
peak for the drug is observed. This phenomenon could be 
attributed due to the drug is uniformly distributed in the polymer 
system as a semicrytalline or amorphous state. The thermal study 
of the thermograms of the solid dispersions of BPG: mannitol 
revealed that the peak height is reduced and had become broader 
in nature indicates that the drug may be present in form of 
dissolution or semicrystalline state.  
SEM 
The BPG: PVP solid dispersions appear in the form of tiny 
aggregates of irregular size pieces whereas; original morphology of 
both components is disappeared. The HPMC solid dispersions 
showed aggregates of irregular particles with porous nature. The 
PEG 4000 and mannitol based formulations showed smooth-
surfaced flaks and needle shape particles. The drug-PEG 4000 
solid dispersion showed the smallest crystalline particles at drug: 
polymer ratio 50:50 that showed obvious increase in size with 
decreasing polymer concentration (70:30). The drug-mannitol solid 
dispersion showed aggregated crystals with smooth surface and 
irregular shape.  
Angle of repose and powder wettability  
The effect of the hydrophilic polymers on the flow behavior of solid 
dispersion was also reported [18,19]. The two hydrophilic polymers 
PEG 4000 and mannitol showed obvious effect on improving the 
wettability of the powder dispersions. Decreasing the wetting time 
may be considered as one of the reasons for improving the drug 
release. Consequently, solid dispersions using PEG 4000 and 
mannitol would be effective in improving the hydrophilic character 
and wettability of BPG. 
Dissolution studies 
The dissolution profiles of BPG were found to depend on the 
carrier used. A rapid initial dissolution rates were observed for all 
solid dispersions.  Increases in dissolution rates were partly 
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dependent on the ratios of BPG to carrier. The least effective 
polymer on improving the drug dissolution was PVP that also had 
retarding effect on the powder wettability. Mannitol allowed fast 
wetting of the drug powder due to its mechanism of disintegrant 
that promote capillary action, absorb moisture, swell and enhanced 
the drug release from the dispersion system. Thus, the 
experiments showed that hydrophilic polymers can be used to 
improve the dissolution characteristics of poorly soluble drug in 
pharmaceutical formulations.  
Conclusion 
The major problem of BPG is its very low dispersion in aqueous 
medium and low solubility in biological fluids. From the present 
study it can be easily demonstrated that hydrophilic polymers 
mannitol, HPMC and PEG 4000 has potential effect on improving 
the wettability and dissolution characters of the drug. The results 
revealed that it is possible to enhance the dissolution rate of BPG 
(hydrophobic drug) by increasing the surface area of the drug 
adsorbed on the surface of hydrophilic polymer by solid dispersion 
method. The formula of BPG: PEG 4000 at ratio 50:50 yielded best 
results in terms of % yield, % EE, flowability, wettability and 
dissolution rate.  
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